These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 26573548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.
    Londoño Jimenez A, Mowrey WB, Putterman C, Buyon J, Goilav B, Broder A.
    Arthritis Rheumatol; 2018 Nov; 70(11):1801-1806. PubMed ID: 29851285
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
    Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, Ai J, Liarski VM, Chang A, Peng Y, Lan L, Westmoreland S, Olson L, Giger ML, Chun Wang L, Clark MR.
    Arthritis Rheumatol; 2016 Nov; 68(11):2740-2751. PubMed ID: 27159593
    [Abstract] [Full Text] [Related]

  • 4. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.
    Kinloch AJ, Chang A, Ko K, Henry Dunand CJ, Henderson S, Maienschein-Cline M, Kaverina N, Rovin BH, Salgado Ferrer M, Wolfgeher D, Liarski V, Haddon DJ, Utz PJ, Wilson PC, Clark MR.
    Arthritis Rheumatol; 2014 Dec; 66(12):3359-70. PubMed ID: 25306868
    [Abstract] [Full Text] [Related]

  • 5. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
    Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS.
    Clin J Am Soc Nephrol; 2008 May; 3(3):682-90. PubMed ID: 18287252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Update on Lupus Nephritis: Core Curriculum 2020.
    Parikh SV, Almaani S, Brodsky S, Rovin BH.
    Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA, Odobasic D, Khouri MB, Steinmetz OM, Yang Y, Holdsworth SR, Kitching AR.
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [Abstract] [Full Text] [Related]

  • 12. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells.
    Omokawa A, Wakui H, Okuyama S, Togashi M, Ohtani H, Komatsuda A, Ichinohasama R, Sawada K.
    Clin Nephrol; 2008 Jun; 69(6):436-44. PubMed ID: 18538120
    [Abstract] [Full Text] [Related]

  • 13. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.
    Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, Meffre E, Clark MR.
    J Immunol; 2011 Feb 01; 186(3):1849-60. PubMed ID: 21187439
    [Abstract] [Full Text] [Related]

  • 14. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis.
    Park MH, D'Agati V, Appel GB, Pirani CL.
    Nephron; 1986 Feb 01; 44(4):309-19. PubMed ID: 3540691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ, Choi SE, Xu H, Kang JH, Lee KE, Lee JS, Choi YD, Lee SS.
    Int J Rheum Dis; 2018 Feb 01; 21(2):458-467. PubMed ID: 29314776
    [Abstract] [Full Text] [Related]

  • 18. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
    Anders HJ, Rovin B.
    Kidney Int; 2016 Sep 01; 90(3):493-501. PubMed ID: 27378475
    [Abstract] [Full Text] [Related]

  • 19. A novel pathogenetic concept-antiviral immunity in lupus nephritis.
    Migliorini A, Anders HJ.
    Nat Rev Nephrol; 2012 Jan 17; 8(3):183-9. PubMed ID: 22249778
    [Abstract] [Full Text] [Related]

  • 20. Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology.
    Lorenz G, Desai J, Anders HJ.
    Curr Opin Nephrol Hypertens; 2014 May 17; 23(3):211-7. PubMed ID: 24662982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.